Kre6p and Sknlp possess COOH-terminal domains with significant sequence similarity to two recently identified glucan-binding proteins.
Deletion of the yeast protein kinase C homolog, PKC1, leads to a lysis defect (Levin, D. E., and E. Bartlett-Heubusch. 1992 . Mutants in the S. cerevisiae PKC1 gene display a cell cycle-specific osmotic stability defect. J. Cell Biol. 116:1221 Biol. 116: -1229 . Kre6p when even mildly overproduced, can suppress this pkcl lysis defect. When mutated, several KRE pathway genes and members of the PKCl-mediated MAP kinase pathway have synthetic lethal interactions as double mutants. These suppression and synthetic lethal interactions, as well as reduced/3-glucan and mannan levels in the pkcl null wall, support a role for the PKC1 pathway functioning in cell wall assembly. PKC1 potentially participates in cell wall assembly by regulating the synthesis of cell wall components, including (1--'6)-/3-glucan. B ut) growth in S. cerevisiae requires regulated cell wall synthesis (Cabib et al., 1982) . Regulation of cell cycle events subsequent to START includes a coordinated regulation of cell wall biosynthetic genes responsible for new cell wall synthesis (Shaw et al., 1991) and polarization of the cytoskeleton towards the site of cell wall growth (Adams and Pringle, 1984; Madden et al., 1992; Lew and Reed, 1993) . Phosphorylation of biosynthetic components involved in cell wall synthesis represents a potential level of regulation that integrates the cell cycle with changes within the wall and ensuing morphological events.
PKC1 encodes a yeast homolog of the mammalian protein kinase C family (Levin et al., 1990) . pkcl null cells possess a G2-specific terminal lysis phenotype believed to be a consequence of a fragile cell wall (Levin and Bartlett-Heubusch, 1992) . PKCl-deleted cells rapidly release their contents into the medium, and as judged by electron microscopy, possess thin cell walls which burst at the bud tip (Errede and Levin, 1993) . The lysis phenotype of pkcl can be partially prevented by the presence of osmotic-stabilizing agents in the medium (Levin and Bartlett-Heubusch, 1992; Paravicini et al., 1992) . PKC1 has been proposed to regulate cell wall synthesis through a bifurcated pathway comprising a MAP kinase cascade on one branch, and a second less well understood branch (Lee and Levin, 1992; Errede and Levin, 1993; . PKC1 is though to act as an upstream regulator of this MAP kinase cascade, based on the isolation of dominant gain of function alleles of the MAP kinase kinase kinase, BCK1 (SLK1/SSP31), which suppress pkcl cell lysis (Lee and Levin, 1992; Irie et al., 1991; Costigan et al., 1992) . Multiple copies of either MKK1 or MKK2, a pair of MAP kinase kinase homologs, are also able to suppresspkcl temperature-sensitive alleles from lysing (Ixie et al., 1993) . Furthermore, at elevated temperatures, null mutations of all members of the MAP kinase cascade also exhibit an osmotic-suppressible lysis phenotype (Errede and Levin, 1993) . MPKI(SLT2) , the MAP kinase at the base of this pathway, has recently been isolated as a dosage-dependent suppressor ofa bckd null mutant and independently isolated according to its cell lysis phenotype (Torres et al., 1991) . MPK1 is suspected to phosphorylate a variety of substrates, including transcription factors, in a manner analogous to the FUS3/KSSl-dependent activation of STE/2 (Errede and Levin, 1993) . Additional components of the PKCl-mediated MAP kinase cascade suppress pkd cell lysis when overproduced; these include PPZ/and PPZ2, a pair of serine/threonine phosphatases, and BCK2, a gene of unknown function . Despite the requirement for PKC1 in maintaining correct cell wall ultrastructure (Paravicini et al., 1992) , its role in regulating cell wall synthesis remains unknown.
Many genes involved in the assembly of cell wall components such as chitin, mannan, and fl-glucan have been identiffed (for reviews see Bulawa, 1993; Ballou, 1990; Klis, 1994) . However, how genes involved in cell wall synthesis are regulated, is poorly understood. Among known cell wall-related genes are a number of K1 killer toxin resistant, or KRE genes, involved in the synthesis of the cell wall polymer (l~6)-/$-glucan (Boone et al., 1990; Meaden et al., 1990; Bussey, 1991; Hill et al., 1992; . The cloned and characterized KRE genes, include two highly homologous genes, KRE6 and SKN1 (Roemer and Bussey, 1991; Roemer et al., 1993) . Disruption of KRE6 results in slow growth and killer resistance, presumably due to a 50% reduction in the wild-type level of cell wall (1--'6)-/$-glucan. Loss of SKN1 has no effect on killer sensitivity, growth, or (l~6)-/~-glucan levels. SKN1 is, however, a functional homolog of KRE6 and can suppress the kre6 null phenotypes in a dosage-dependent manner. Deletion of both KRE6 and SKN1 results in a severe growth defect which can be lethal in some strain backgrounds. The slow growth defect of viable kre6 sknl null deletion strains can be partially alleviated by the accumulation of spontaneous extragenic suppressors. Such kre6 sknl null suppressed strains possess little, if any, (l~6)-/3-glucan. Because KRE6 and SKN1 are required for the majority of this polymer, and since single disruptions of either gene lead to structurally wild-type (1-,6),~-glucan, KRE6 and SKN1 have been proposed to function independently and to act early in the assembly of the polymer, possibly as glucan synthases.
The KRE6 and SKN1 gene products, Kre6p and Sknlp, have been characterized to further examine their role in (l~6)-/$-glucan assembly. Here, KRE6 and SKN1 are shown to encode phosphorylated integral-membrane glycoproteins that are likely localized to the Golgi apparatus. The topology implied by the posttranslational modifications of Kre6p and Sknlp, offers the potential for both proteins to link cytoplasmic regulation with the secretory pathway-based assembly of the (l~6)-/$-glucan polymer. The observed phosphorylation of both Kre6p and Sknlp prompted an examination for genetic interactions with suspected cell wall regulating kinases. KRE6-dependent suppression of the pkcl lysis defect, as well as synthetic lethal interactions between several KRE genes and members of the PKCl-mediated MAP kinase pathway, support the contention that a role of the PKC1 pathway is to act on cell wall assembly.
Materials and Methods

Yeast Strains, Media, and Methods
Yeast strains used in this study are listed in Table I . Media for yeast growth and sporulation were as described in Guthrie and Fink (1991) . YPD is yeast complex medium; YNB is a synthetic medium that was supplemented with appropriate nutrients. Low phosphate minimal medium was prepared according to Haguenauer-Tsapis and Hinnen (1984) . Yeast mating, sporulation, and tetrad analysis were performed as described in Guthrie and Fink (1991) . Resistance and sensitivity to K1 killer toxin was scored by the seeded plate assay of Bussey et al. (1982) and Hutchins et al. (1983) . Yeast transformations were by the lithium acetate method of lto et al. (1983) using 100/~g of sheared, denatured carrier DNA (Schiesfl and Gietz, 1989) .
Cell Wall Analysis
Analysis of the composition of the pkclA cell wall proved difficult due to its cell lysis phenotype. Osmotic-stabilizing agents, although required for pkclA cell growth, distort sample weights significantly and prevent polymer levels being normalized to dry weight of cells, pkclA cell lysis also precluded the option of washing away the osmotic supplement before sample weighing. Normalizing cell wall polymer levels to the wet weight of cells is also likely to be inaccurate with such lyric strains. To attempt to overcome these problems, cell walls from the various strains were isolated, as described by Van Rinsun et al. (1991) , and all cell wall polymer measurements were normalized per mg cell wall dry weight. The pkclA strain, GPYI115, was extremely sensitive to glass bead agitation; lysing completely after a few brief vortex pulses. 500-ml cultures of GPYlll5 harboring either pRS315 or pRS315-KRE6 plasmids were grown to mid log in YNB supplemented with 0.5 M KC1. Two 100-ml aliquots of each culture were processed to provide an accurate cell wall dry weight determination. Three 100-ml aliquots of each culture were processed to determine/~-glucan levels. Alkali-insoluble (l'-"6)-t3-glucan and (l~3)-~-glucan were isolated after NaOH extractions according to Boone et al. (1990) . Alkali-soluble (l~3)-/$-glucan levels were estimated from NaOH extraction supernatants by precipitating carbohydrates with two volumes of ethanol at -20°C. carbohydrates were measured as hexose as described by Badin et al. (1953) . Mannoprotein was isolated from 250-ml cultures of GPY1115 transformed with KRE6, PKC1, or control plasmids grown to mid log in 0.5 M KCl-supplemented YNB, according to Ballou (1990) . Mannan levels were determined by measuring bexose, and normalized to the cell wall dry weight determined from an additional 100-mi of each culture.
Electron Microscopy
Tetrads from strains TR67 and TR160 were dissected to isolate fresh kre6A and skn/A haploid strains TR510 and TR511, respectively. TR512 is a congenie wild-type spore progeny from TR67. TR211 and TR213 are kre6A skn/A strains possessing independently derived extragenic mutations which partially suppress their slow growth phenotype. 10-mi cultures of TR211, TR213, TR510, TRSI1, and TRS12, were grown in YPD to a cell density of 107/ml and processed as described by Boone et al. (1990) with the single modification that samples were embedded in Epon. Sections were viewed on a Philips EM410 electron microscope at an opening voltage of 80 kV. TR211 and TR213 cell wall ultrastructure phenotypes were indistinguishable. 
Epitope Tagging
Standard molecular manipulations were as described by Sambrook et al. (1989) . Epitope tagging of Kre6p and Sknlp was performee as described by Kolodziej and Young (1991) . The following complementary oligonucleotides encoding the influenza virus hemagglutinin (HA) l sequence in frame with SKN1 and KRE6 open reading frames were designee: SKN1 oligos 429 (TACCCATACGACGTCCCAGACTACC.d2TTCTC~:~A) and 430 (GAA-GCGTAGTC~CGTCGTATGC~TAT) and KRE6 oligos 598 (GAT-CTCAACTACAACCCATACGACGTCCCAGACTACGCT) and 599 (GAT-CAGCGTAGTC'IU)GGACGTCGTA~TTGTAGTTGA). Oligos 429 and 430 were annealed and subclonee into the corresponding PstI site of YEp352-SKN1. Similarly, oligos 598 and 599 were annealee and ligatee into the unique Bgl~I site of YEp24-KRE6 and pRS315-KRE6. Subclones possessing the epitope insertion could be identified by restriction mapping a unique AatII site (shown in bold) present in the oligonuclcotide sequence. A selection for positive subelones that possessed the oligonuclcotide sequence in the correct orientation, was facilitated by introducing an in-frame stop codon (shown underlined) to truncate the protein when the oligonucleotides were ligatee in the incorrect orientation. Thus, transforming AatlI + subciones into the kre6A strain, TR92, yielded two populations of transfor-
Abbreviations used in thispaper:
BB, breakage buffer; HA, influenza virus hemagglutinin; Kretp-HA, epitope-taggee version of Kre6p; PAS, protein A Sepharose; Sknlp-HA, epitope-taggee version of Sknlp; WB, wash buffer. mants; one of fast growing killer toxin sensitive transformants that harbor the correctly taggee construct, and a second population of slow growing killer toxin resistant transformants possessing AatII + subclones whose oligonucleotides were ligated in the incorrect orientation. Functional epitope taggee versions of these plasmids were named YEp352-SKN1-HA, YEp24-KREt-HA, and pRS315-KREt-HA, respectively.
Cell Labeling and lmmunoprecipitations
Cell labeling and immunoprecipitations were performee essentially as described by Cooper and Bussey (1989) . 10-ml cultures of 107 cells were grown up in appropriate minimal medium for 35S-or 32p-labelihg, harvestee, concentrated fourfold, and grown an additional 30 min in fresh minirnal medium. Cells were labeled with either 100 #Ci of Trans 35S-label or carrier-free [32p]orthophosphate (ICN Biocbemicals, Irvine CA) for 15 rain with shaking. Tunicamycin-treatee cultures (10 /~g/ml) were preincubatee with the drug 30 min before labeling. After labeling, cultures were pelleted by centrifugation, and washed with ice-cold breakage buffer (BB) (150 mM NaCI, 10 raM Na2 B407 [pH 8.0]). Cells were resuspendee in 65 #1BB, supplemented with 1.5 #g/ml leupeptin, 3 ~,g/ml pepstatin A, 1 mM PMSF, and a 50-100-#1 vol of acid-washee glass beads (0.45-0.5-mm pore diameter) was addee. (A pbosphatase inhibitor, 5 mM sodium molybdate, was also added in 32p-labeling experiments.) Samples were left on ice for 10 rain, and then vortexee strongly 15-20 times for 20 s intervals, with alternating short incubations on ice. Membrane proteins were solubilized with the addition of 10 #t 10% SDS, and incubated for 5 rain at 95°C. Samples were cooled to room temperature, centrifuged 1 rain, and supernatants collected and diluted 10-fold in 1.0 ml reaction buffer (RB) (50 mM Tris-HCt pH 8.0, 150 mM NaC1, .1% Triton X-100, 1 mM EDTA, 2 m~/ml BSA, 1.5 /~g/ml leupeptin, 3 #g/ml pepstatin A, 1 mM PMSF [including 5 mM sodium molybdate in 32P-labeling experiments]). Samples were centrifuged again for I rain and supernatants transferred to fresh tubes. To diminish the nonspeeific binding of radiolaboled proteins, 100/~1 protein A-Sepharose (PAS) (CI-4B, Pharmacia LKB Biotechnology, Piscataway, NJ) was added and samples were incubated at 40C for 1 h with rotation. Supernatants were collected and transferred to a fresh tube, to which a 1:150 dilution of the 12CA5 monoclonal antibody (Berkeley Ab Company, Berkeley, CA) was added. Samples were incubated with 12CA5 at 4°C with rotation for 2 h, and then immunopreeipitated after a 1-h incubation at 4°C with rotation, with the addition of 50/xl PAS. (To remove radiolabeled RNA from 3~p_ labeling experiments, ~200/~g RNase A was added and incubated for an additional 30 rain at 4°C). After immunoprecipitations, samples were subjected to a brief centrifugation to pellet PAS beads. Immunoprecipitates were washed four times in wash buffer (WB) (50 mM Tris-HCl pH 8.0, 150 mM NaCI, 0.1% Triton-X-100), and finally suspended in 50 td Laemmli loading buffer, boiled 5 min, and analyzed by SDS-PAGE. Fluorography of 35S-labeled samples was enhanced by bathing gels in a 1.0 M sodium salicylate solution before drying.
Labeling and immunoprecipitation of Kre6p-HA in the pkcl null strain GPYIll5, as well as its isogenic wild-type parent strain, SEY6210, were carried out as described above, in low phosphate media supplemented with 0.5 M KC1. Kre6p-HA protein levels were determined by Western analysis.
Endo H Digestion
Immune complexes bound to PAS were washed three times with WB, followed by two additional washes in 1.0 ml of 100 mM sodium citrate (pH 5.5). Samples were then resuspended in 200 ml sodium citrate buffer contalning the above protease inhibitors, and digested with 10 mU Endo H (or mock digested) overnight at 37°C. Samples were then washed twice with WB, and processed as described for 35S-labeled samples.
Extraction of Membrane Proteins
Membrane association of both Kre6p and Sknlp was determined as described by Ljungdahl et al. (1992) . Protein extracts from 50-ml cultures expressing Kre6p-HA or Sknlp-HA were prepared by glass bead lysis, and centrifuged at 1,000 g to remove nonlysed cells. Supernatants were removed and split into five separate 80-t~l fractions. Four fractions were adjusted to a final concentration of either 0.1 M Na2CO3 (pH 11.0), 0.5% Triton X-100, 1.6 M urea, or 0.6 M NaC1, in a final volume of 200 t~l. These samples were incubated 15 min on ice, and fractionated by high speed centrifugation (150,000 g for 15 min at 4°C). A fifth sample was diluted to 200 ILl with BSB, and subjected to a low speed spin of 14,000 g for 10 min. The pellet and supernatant fractions for all samples were collected and solubilized in Laemmli buffer at 95°C before analysis by SDS-PAGE. Western blots were performed using a 1:2,000 dilution of 12CA5 antibody, and 1:1,000 of horseradish peroxidase-conjugated goat anti-mouse secondary antibody, and developed using the ECL chemiluminescence detection kit (Amersham Canada, Oakville, Ontario).
Indirect Immunofluorescence Microscopy
Exponentially growing wild-type yeast strains harboring plasmids encoding either epitope-tagged Kre6p-HA constructs, or native Kre6p were fixed with 3.7% formaldehyde, and treated for immunofluorescence microscopy using standard techniques (Pringle et al., 1991) . Antibody dilutions were 1:3,000 and 1:1,000 for 12CA5 and Texas red-conjugated goat anti-mouse secondary antibody, respectively. Cells expressing epitope-tagged Kre6p (Kre6p-HA) were viewed under Texas red excitation wavelengths to indicate the subeellular localization of Kre6p, and under 4',6-diamidino-2-pbenylindole (DAPI) excitation irradiation to visualize DNA. Images were obtained using a Zeiss Axioplan Microscope, and represent '~ a 2,000-fold magnification.
Homology Search
Amino acid sequences of Kre6p and Sknlp were compared with all entries in GenBank non-redundant protein sequence database Release 81 (February 15, 1994) (Altschul et al., 1990) . Computer alignment was created using GENE WORKS (Intelligenetics, Inc., Mountain View, CA).
Results
KRE6 and SKN1 Are Required for Normal Cell Wall Ultrastructure
To further explore phenotypes associated with the loss of the KRE6 and SKN1 genes, the cell wall ultrastructure of kre6A, sknlA, and kre6A sknlA strains was examined by electron microscopy. A correlation was found between the loss of cell wall integrity and the severity of mutant phenotypes.. The kre6 null strain has an altered cell wall ultrastructure reminiscent of that previously seen in both krel and kre9 null mutants ( Fig. 1) (Boone et al., 1990; . The kre6 null cell wall lacks a darkly staining outer layer through to be composed primarily of rnannoproteins (Zlotnik et ai., 1984) . The thick central layer of the cell wall, composed largely of B-glucan (Zlotnik et al., 1984; Horisberger and Clerk, 1987) , was also noticeably different in kre6 null cells, appearing more amorphous than wild-type cell walls. In contrast, the strain deleted for SKN1, which alone shows no pronounced cell wall phenotype, possessed a cell wall ultrastructure similar to that of the wild-type, kre6 skn/null strains display a dramatic alteration in cell wall ultrastructure, lacking the darkly staining marmoprotein outer layer and also appearing to be significantly thicker and often delaminated.
Kre6p and Sknlp Share Homology with Glucan-binding Proteins
Kre6p and Sknlp share similarity to portions of the recently identified Rhodotherraus marinus (1-*3)-/~-glucanase, bglA (Spilliaert, R., G. O. Hreggvidsson, J. K. Kristjansson, G. Eggertsson, and A. Palsdottir, unpublished results) and the (1-*3)-/~-glucan dotting factor, FGA, from horseshoe crab (Seki et al., 1994) (Fig. 2) . FGA shares similarity to 0-*3)-~-glucanases throughout its amino terminal domain and binds (1-*3)-/~-glucan to initiate an immune response against invading fungi. The bglA and FGA proteins share significant homology within two 100-amino acid stretches of both the Kre6p and Sknlp COOH-terminal domains. Kre6p and Sknlp also share similarity to a portion of the bacterial (1-*3)-/~-glucanase active site amino acid sequence, Glu*-Ile-Asp-Ile-Glu; including its proposed active site catalytic nucleophile Glu* (Hoj et al., 1992; Planas et al., 1992) .
Immunodetection of Kre6p and Sknlp
We sought to identify the KRE6 and SKN1 gene products, as an initial step in their characterization. Epitope-tagging of Kre6p and Sknlp was carried out by inserting a 9-amino acid segment of the HA protein (Kolodziej and Young, 1991) into the amino-terminal domain of each protein. Epitope-tagged versions of both Kre6p (Kre6p-HA) and Sknlp (Sknlp-HA) functioned as the wild-type gene products, as judged by both growth restoration and the ability to confer toxin sensitivity in the kre6A strain, TR92 (data not shown).
Immunoprecipitations from whole cell extracts using anti-HA monoclonal antibody, 12CA5, specifically detected Kre6p-HA and Sknlp-HA proteins (Fig. 3 ). Kre6p and Sknlp are predicted to encode 80-and 85-kD proteins, respectively. Their actual mobilities are substantially slower than predicted; in the apparent molecular mass range of 120 kD for Kre6p-HA and 125-130 kD for Sknlp-HA. Interestingly, Sknlp-HA migrates as a doublet, with the major form migrating slightly slower than the minor species. Whether these two forms of Sknlp-HA are the resuk of proteolysis, or represent some other protein modifications has not been determined.
Kre6p and Sknlp are quite acidic, with predicted pI's of 4.2 and 4.4, respectively. As often reported for acidic proteins (Cooper et al., 1989) , their anomalous apparent molecular mass could partly be a reflection of reduced SDS binding and distortion of their charge/mass ratio. However, Kre6p and Sknlp are also predicted to possess substantial cytoplasmic and lumenal domains accessible to a variety of potential posttranslational modifications which may also contribute to their mobility on SDS-PAGE.
Kre6p and Sknlp Are N-Glycoproteins
Glycosylation could contribute to the anomalous mobility of Kre6p and Sknlp. To examine this possibility, the mobilities of both Kre6p and Sknlp from both tunicamycin-treated and non-treated cell cultures were compared. Tunicamycin- Residues conserved by at least one member of each pair of protein sequences are boxed. Homology to the bacterial #-glucanase active site sequence, Glu-Ile-Asp-Ile-Glu, is underlined. An asterisk identifies the proposed catalytic nucleophile (Hoj et al., 1992; Planas et al., 1992) . Gaps (---) have been introduced to improve alignments. Accession numbers for FGA and bglA are D16622 and U04836, respectively. treated cell cultures expressing either Sknlp-HA or Kre6p-HA show a 10-kD increase in mobility relative to untreated control cultures (Fig. 4 A) . Similar mobility shifts were detected when treating immunoprecipitated Sknlp-HA or Kre6p-HA (data not shown) with the endoglycosidase, Endo H (Fig. 4 B) . Asparagine-linked glycoproteins contain a GlcNAc2Man9 Glc3 core moiety that is attached and modified in the ER (Abeijon and Hirsehberg, 1992) , and often extended with outer chains later in the secretory pathway (Herscovics and Orlean, 1993) . Strains possessing a mnn9 mutation are unable to elaborate N-linked core oligosaccharides (Ballou, 1990) , and allow one to discern whether such outer chain modifications occur in a given N-glycoprotein. Kre6p-HA and Sknlp-HA were expressed in the mnn9 strain LB3003-2Aa, and their electrophoretic mobilities compared to those in wildtype strain SEY6210 (data not shown). The absence of any detectable mobility shift in the mnn9 strain, compared with wild type, suggests that both Kre6p and Sknlp are exclusively core-glycosylated. As each asparagine-linked core oligosaccharide is composed of • 2.5-kD of carbohydrate and as no mnn9-dependent core elaboration was detected, the 10-kD N-linked glycosylation mobility shift suggested that 4-5 core oligosaccharides are attached to both Kre6p and Sknlp. This number is consistent with the 5 and 6 potential N-linked glycosylation sites within the respective COOH-termini of Kre6p and Sknlp. N-linked glycosylation does not appear to be solely responsible for the slow mobility of Kre6p and Sknlp, since both tunicamycin-treated species continue to migrate significantly more slowly than their protein sequences predict. Possible O-linked glycosylation was examined using a null mutation of KRE2 which encodes a mannosyltransferase required for complete O-linked glycosylation (Hausler et al., 1992; Hill et al., 1992) . Both Kre6p-HA and Sknlp-HA were produced into the kre2A strain, TR520, and their mobilities compared with those in a wild-type strain, SEY6210. No obvious KRE2-dependent mobility shift was detected (data not shown).
Kre6p and Sknlp Are Integral Membrane Proteins
Kre6p and Sknlp both possess a conserved stretch of 30 hydrophobic amino acid residues predicted to adopt an alphahelical secondary structure capable of spanning a membrane. To examine possible membrane association, TR92 whole cell extracts containing Kre6p-HA or Sknlp-HA were treated with 0.1 M Na2CO3 and separated by high speed centrifugation into supernatant and pellet fractions. Both Kre6p-HA and Sknlp-HA fractionated exclusively to the Figure 5 . Membrane association of Kre6p-HA and Sknlp-HA. Cell lysates from strain TR92, expressing either Kre6p-HA or Sknlp-HA, were subjected to either a low speed spin (LSS), or incubated in 0.1 M Na2CO3, 0.5% Triton X-100, 1.6 M urea, or 0.6 M NaC1, as described in Materials and Methods. Cell lysates were then separated into pellet (P) and supernatant (S) fractions by high speed centrifugation, analyzed by Western blotting with 12CA5, and visualized by ECL fluorography. membrane pellet after high speed centrifugation (Fig. 5) . Similar fractionation profiles for both proteins were seen using high salt (0.6 M NaCI) or denaturing conditions (1.6 M urea). Conversely, detergent treatment using 0.5% Triton X-100 solubilized the majority of Kre6p-HA and Sknlp-HA.
Kre6p Appears Localized to the Golgi Apparatus
Initial synthesis of (l~6)-~/-glucan has been proposed to occur early in the secretory pathway based on the characterization of KRE5 (Meaden et al., 1990) . KRE5 lacks any detectable (1---6)-/~-glucan when deleted, and encodes a secretory protein possessing the COOH-terminal amino acid sequence, HDEL; a retention signal for soluble ER proteins (Pelham et al., 1988) . As Krerp and Sknlp also define an early event in the polymer's synthesis, the localization of these secretory proteins was sought. Indirect immunofluorescence microscopy of TR92 maintaining a 2 /~m-based Kre6p-HA construct revealed a punctate-staining pattern suggestive of Golgi localization in yeast (Fig. 6) (Preuss et al., 1992; Redding et al., 1991; Nothwehr et al., 1993; Cooper and Bussey, 1992) . A variability in both the number of stained punctate spots per cell and the number of ceils stained per field was found. Such variability in staining likely reflects variation in protein abundance; a phenomenon commonly seen using 2 /zm-based plasmids (Redding et al., 1991) . The specificity of the immunofluorescence signal to Kre6p-HA was demonstrated by the observation that identical strains transformed with the same 2 /zm-based Kre6p construct lacking the HA epitope and identically processed, failed to provide any immunofluorescence signal.
Attempts to localize Kre6p-HA expressed from a centromeric-based plasmid proved unsuccessful. Although overexpression can lead to mislocalization, overexpression of secretory membrane proteins is not believed to result in a mislocalization to the Golgi; instead mislocalization to the vacuole, and some accumulation in the ER are documented (Roberts et al., 1992; Nothwehr et al., 1993; Cooper and Bussey, 1992) . Of over 1,100 Kre6p-HA cells giving a clear staining pattern, more than 1,000 showed strong punctate staining, while only ~150 showed strong punctate plus weaker perinuclear (ER) staining. Less than 1% of Kre6p-HA cells showed faint perinuclear staining only, and no cells had vacuolar or cell surface staining. These observations suggest that Kre6p resides within a Golgi compartment.
Preliminary experiments using Sknlp-HA rule out a cell surface localization, where under identical conditions we detect an equivalently abundant HA-tagged KRE/protein (to be published elsewhere). We are, however, unable to distinguish whether Sknlp-HA resides in an ER or Golgi intracellular location.
Kretp and Sknlp Are Phosphorylated Proteins
Both Kretp and Sknlp are predicted to possess substantial cytoplasmic domains that are amino-terminal to their transmembrane domain (Harthann et al., 1989; Parks and Lamb, 1991) and that are potential substrates for protein kinases. To examine possible phosphorylation of these proteins, TR92 transformed with either Kre6p-HA or Sknlp-HA expressing plasmids, or an untagged control construct was grown in the presence of [32p]orthophosphate and immunoprecipitated (Fig. 7 ). Kre6p and Sknlp are both phosphorylated as shown by appropriately sized signals on SDS-PAGE that are absent from control samples. 32p-labeled Kre6p-HA and Skidp-HA were similarly detected in a mnn9 background and in tunicamycin-treated cell cultures, indicating that the phosphorylation of Kre6p and Sknlp is due neither to phosphodiester linkages in N-linked outer chains nor to phosphorylation of N-linked core oligosaccharides (data not shown). Instead, Kre6p and Sknlp are phosphorylated on either serine/threonine or tyrosine residue(s). Consistent with this, phosphatase digestions removed radiolabel from 32p-labeled Kre6p-HA and Sknlp-HA immunoprecipitates, and enhanced their electrophoretic mobility slightly when these proteins were 35S-labeled (data not shown). As both proteins contain NH:-terminal domains composed of 21% serine and threonine residues, several different phosphorylation site consensus sequences are evident; including those of PKC1, MAP kinase, cAMP-dependent protein kinase, and casein kinase (Kemp and Pearson, 1990) .
KRE6 Suppresses the Lysis Phenotype of pkcl, but Not Defects in the MAP Kinase Branch of the PKC1 Pathway
Recent work has implicated the yeast PKC1 pathway in regulating cell wall growth (Levin and Bartlett-Heubusch, 1992; Paravicini et al., 1992) . Disruption of PKC1 results in a lysis phenotype, which can be prevented by the addition of osmotic support to the medium (Levin and BartlettHeubusch, 1992; Paravicini et al., 1992) . As both Kre6p and Sknlp are phosphoproteins required for cell wall synthesis, possible genetic interactions between the KRE6, SKN/, and PKC1 were examined. Both centromeric and 2 /zm-based KRE6-containing plasmids transformed into the pkclA strain, GPY1115, are capable of alleviating the pkcl osmotic lysis lethality when grown on YPD (Fig. 8) (data not shown). Overexpression of SKN1, failed to suppress the pkc/ null lethality on non-osmotically supplemented media (data not shown). PKC1, when overexpressed from a multicopy construct, did not suppress the slow growth phenotype or killer resistance of a kre6 null mutation (data not shown).
As KRE6 is one of several KRE genes participating in (1--'6)-/5-glucan synthesis, additional KRE genes were tested for their ability to suppress thepkcl lysis phenotype. KRE/1, encoding a candidate regulatory component localized to the cytoplasm Brown, J., personal communication) , as well as KRE/ and KRE9, encoding secretory proteins involved in (l'~'6)-/3-glucan assembly (Boone et al., 1991; , were all incapable of rescuing pkcl lethality on YPD (data not shown).
The PKC1 pathway is thought to be branched, and we asked whether KRE6 could suppress defects in the MAP kinase branch of the PKCl-mediated pathway. Centromeric and 2/zm-based KRE6 plasmids were transformed into mpk./, and nddd,2, null strains, and examined for growth at 37°C in the absence of osmotic-stabilizing supplements. Neither mpk/ nor ink/c/,2 null strains were rescued from their temperature-sensitive lysis phenotype on YPD by additional copies of KRE6 (data not shown).
Synthetic Lethal Interactions between KRE6 and Components of the PKCl-mediated M A P Kinase Cascade
To investigate possible additional genetic interactions be- tween kre6A and pkclA, the kre6A pkclA double heterozygote TR500, was sporulated and dissected onto osmotically supplemented YPD medium. Tetrad analysis of spore progeny indicated that the pkcl kre6 double mutant spores were inviable, either on sorbitol or KCl-supplemented YPD plates (Table ID. The pkcl kre6 null spores germinated but invariably arrested with a small-to medium-sized bud. Additional synthetic lethal interactions were found between kre6 and both mpkl and m/dr,2 double nulls at 30°C, which were also not rescued by osmotic supplements (Table II) .
Synthetic Lethal Interactions between PKC1 and Other Cell Wall-related Genes
To address if synthetic lethality between pkcl and kre6 is due specifically to an exaggerated (l~6)-/3-glucan defect, or whether other cell wall perturbations in combination with pkcl can also cause lethality, genetic interactions between PKC1 and other cell wall-related genes were examined. KRE/1-deleted strains possess a (l~6)-/3-glucan phenotype comparable to kre6 null strains . Tetrad dissection of the pkcl kre11 double heterozygote diploid strain, TR502, revealed pkcl kre11 spores to be inviable on 1.2 M sorbitol-supplemented YPD (Table II) . pkcl kre11 segregants invariably died after 2-5 cell divisions. A null mutation in KRE2, a marmosyltransferase required for correct O-linked glycosylation of marmoproteins (Hausler et al., 1992; Hill et al., 1992) , also conferred a synthetic lethal phenotype in combination with pkcl on sorbitol-supplemented YPD. In contrast, skn/mutants which lack any obvious cell wall phenotype fail to show an exaggerated growth defect in combination with pkcl (Table II) . In addition, combining kre6 and kre2 mutations lacked any synergistic growth defect (Table II) . 
pkcl A Cells Have an Altered Cell Wall
Growth in osmotic-supplemented media does not result in substantial changes to the cell wall of pkcl null cells since transfer to a low osmoticum after growth in osmotic-supplemented conditions leads to immediate pkcl cell lysis (Paravicini et al., 1992) . To examine the composition ofthepkcl null cell walls, GPYlll5 and the isogenic wild-type strain SEY6210 were grown in the presence of osmotic support, and their cell walls purified. Fractionation and quantitation of the various cell wall components revealed thatpkclA cells lack a significant amount of all /3-glucan polymers when compared with wild type (Table Ill A) . These results, showing an overall reduction of 30% in total B-glucan in a pkcl mutant, are very similar to those reported recently by Shimizu et al. (1994) . Mannan, the other major wall component, was modestly reduced by 20% in this pkcl-deleted background (Table In B) . To address whether KRE6 suppression occurs through possible remodeling of the pkcl cell wall, GPYlll5 strains harboring a variety of KRE6 or control plasmids were grown in 0.5 M KCl-supplemented media and their cell wall polymer levels compared. No significant increase in (1-*6)-Bglucan, (1-*3)-B-glucan, or mannan were seen in GPYlll5 transformed with KRE6 (Table III, A and B) . Thus, although the cell wall of GPYlll5 is very different from wild type, possessing reduced levels in all/3-glucan polymers and mannan, the partial KRE6 suppression of the pkcl osmotic lysis phenotype is not accompanied by an obvious restructuring of the wall.
Discussion
Our study addresses a number of new issues in the synthesis and regulation of an extracellular matrix polymer in S. cerevisiae. Previous work indicates that Kre6p and Sknlp are candidates for/3-glucan biosynthetic enzymes (Roemer and Bussey, 1991; Roemer et al., 1993) . The/3-glucan and cell wall ultrastructural effects seen in kre6 sknl mutants, and the sequence similarity of regions of Kre6p/Sknlp to/3-glucanbinding domains of other proteins, support this contention. The Golgi localization of Kre6p is consistent with, and extends, previous work suggesting a sequential secretory pathway-based synthesis of (1-*6)-B-glucan beginning in the ER, continuing within the Golgi, and being completed at the cell surface (Boone et al., 1990; Meaden et al., 1990) . The relative frequency of Kre6p staining patterns in secretory organelles is inconsistent with an alternative interpretation that Kre6p is normally localized to the ER, but is mislocalized to the Golgi once the ER is saturated. Epistatic relationships between KRE6 and KRE5 and KRE6 and KRE/(Boone et al., 1990; Meaden et al., 1990) are consistent with a Golgi localization of Kre6p; with Kre6p acting downstream of a KRESdependent ER event, and being epistatic to the KRE/-dependent cell surface event. A secretory pathway location for (1-*6)-B-glucan synthesis is also supported by work of Horisberger and Clerc (1987) who have shown by immunogold labeling of (1-*6)-fl-glucan, that both intracellular and cell wall staining are observed.
(1-*6)-B-glucan assembly in yeast likely parallels extracellular matrix polysaccharide synthesis in higher plants, where for example xyloglucan and pectin are synthesized within the secretory pathway and deposited within the cell wall (Moore and Staehelin, 1988; Zhang and Staehelin, 1992; Levy and Staehelin, 1992; Driouich et al., 1993; Gigeaut and Carpita, 1993) .
A body of biochemical evidence suggests that at least some (1-*6)-/~-l>glucan occurs as a glucosyl moiety on glycoproteins (Van Rinsum et al., 1991; Klis, 1994 ) and the/3-glucosylasparagine linkage has recently been found on laminin (Schreiner et al., 1994) . Our work identifying genes whose products act to assemble this glucan polymer, could well be explained by a set of components involved in such protein glucosylation. This view of (1-*6)-/3-glucan biosynthesis as a newly described form of protein glycosylation would place the polymer in a conventional biochemical context. In yeast, both N-and O-mannosylation of proteins are paradigm examples of glycans synthesized sequentially in the secretory pathway, and subsequently secreted and assembled into the cell wall (Kukuruzinska et al., 1987) .
Demonstration of Kre6p and Sknlp as membrane proteins with both phosphorylation and N-glycosyl modifications, indicates that these proteins possess both cytoplasmic and lumenal domains. Consistent with a type II membrane topology for Kre6p and Sknlp, where their COOH-terminal domains would be lumenal, the COOH-termini of both proteins possesses substantial homology with a pair of secreted/ extracellular glucan-binding proteins. Such a type II topology has the potential to allow Kre6p and Sknlp to couple cytoplasmic and lumenal secretory processes to effect (1-*6)-B-glucan synthesis.
We have examined the relationship between KRE6 and SKN/and other KRE genes, with kinases implicated in the regulation of cell wall synthesis. Genetic interactions between KRE2, KRE6, KREll, SKN1, and PKC1 support the contention thatpkcl cells lyse as a result of a fragile cell wall. The basis of synthetic lethality for the kre6 pkcl and krell pkcl double mutants is not known, but is consistent with a further weakening ofthepkcl cell wall, presumably by exaggerating the (l~6)-/~-glucan defect. Colethality between kre2 and pkcl suggests that the reduced synthesis of O-mannosyl moieties of glycoproteins exacerbates the pkcl cell wall defect. Moreover, as mutants with defects in either the KRE2 or KRE/1 genes alone grow quite well, their synthetic lethality with a defective PKC1 underscores the fragile nature of the pkcl cell wall. Osmotic stabilizers are insufficient to rescue these synthetically lethal combinations, probably because the biosynthesis of wall components has been too severely affected.
Expression of KRE6 from a centromeric plasmid is sufficient to partially suppress the osmotic lysis phenotype of a pkcl null mutant. Of the cell wall-related genes tested, only KRE6 has this ability; other participants in the (1--~6)-/3 -glucan synthetic pathway, including Sknlp, cannot suppress the pkd lysis phenotype when overexpressed. Despite this evidence of a special role for KRE6, we have no direct evidence that Kre6p acts as a glucan synthase component in the suppression. KRE6 transformants in the pkcl strain showed no obvious increase in (1--'6)-/~-glucan, or other cell wall polymer. The possibility remains, however, that a modest (1--'6)-/~-glucan or other cell wall alteration does occur with additional copies of KRE6, and that this does improve the condition of the cell wall, but that this alteration is below our relatively crude levels of detection.
A number of lines of evidence strongly indicate that PKC1 affects multiple cell wall synthetic events, and does not act on (1--"6)-/3-glucan synthesis alone. We have shown the pkcl null mutant lacks a significant amount of all cell wall/~-glucan polymers, as well as mannan. This reduction in wall mass likely reflects the thinner, more fragile nature of the pkcl wall. pkclA cells also lack the characteristic cell wall ultrastructure evident in krel, kre6 and kre9-deleted strains, and are osmotically fragile, unlike kre mutants. In addition, suppression of pkcl defects by KRE6 is only partial.
PKC1 is thought to act through a MAP kinase cascade suspected of regulating multiple functions, and a second unknown regulatory branch. KRE6 suppression of pkcl does not act primarily downstream of this MAP kinase branch of the PKC1 pathway, since KRE6 does not suppress the conditional lysis phenotype of mpkl(slt2) or mkk/,2 null strains. We have not, however, ruled out the possibility that the MAP kinase pathway partially regulates KRE6 expression.
Is there a relationship between the KRE6 homolog, SKN1, and PKCI?. The lack of either colethality or suppression of pkcl by SKN1 could indicate a direct activation of Sknlp by Pkclp, such that in the absence of Pkclp, Sknlp is completely inactivated. Alternatively, there may be no relationship between SKN1 and PKC1, and the absence of any genetic interaction simply reflects the minor role SKN/plays relative to KRE6 during vegetative growth.
Our results suggest two plausible relationships between PKC1 and KRE6 in (1--~6)-/3-glucan assembly. One model (See Fig. 9 A) is that KRE6 and the (1--'6)-/~-glucan pathway function in a manner that is independent of the PKC1 path- 
